[1]	YOUNOSSI ZM, KOENIG AB, ABDELATIF D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016, 64(1): 73-84. DOI: 10.1002/hep.28431. 本文引用 [1]

[2]	ADAMS LA, ANSTEE QM, TILG H, et al. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases[J]. Gut, 2017, 66(6): 1138-1153. DOI: 10.1136/gutjnl-2017-313884. 本文引用 [1]

[3]	FRIEDMAN SL, NEUSCHWANDER-TETRI BA, RINELLA M, et al. Mechanisms of NAFLD development and therapeutic strategies[J]. Nat Med, 2018, 24(7): 908-922. DOI: 10.1038/s41591-018-0104-9.

[4]	DAY CP, JAMES OFW. Steatohepatitis: A tale of two “hits”?[J]. Gastroenterology, 1998, 114(4): 842-845. DOI: 10.1016/S0016-5085(98)70599-2. 本文引用 [1]

[5]	OTTERBEIN LE, FORESTI R, MOTTERLINI R. Heme oxygenase-1 and carbon monoxide in the heart: The balancing act between danger signaling and pro-survival[J]. Circ Res, 2016, 118(12): 1940-1959. DOI: 10.1161/CIRCRESAHA.116.306588. 本文引用 [1]

[6]	FAROMBI EO, SURH YJ. Heme oxygenase-1 as a potential therapeutic target for hepatoprotection[J]. J Biochem Mol Biol, 2006, 39(5): 479-491. DOI: 10.5483/bmbrep.2006.39.5.479. 本文引用 [1]

[7]	TAKAHASHI T, MORITA K, AKAGI R, et al. Heme oxygenase-1: A novel therapeutic target in oxidative tissue injuries[J]. Curr Med Chem, 2004, 11(12): 1545-1561. DOI: 10.2174/0929867043365080.

[8]	SLEBOS DJ, RYTER SW, CHOI AMK. Heme oxygenase-1 and carbon monoxide in pulmonary medicine[J]. Respir Res, 2003, 4(1): 7. DOI: 10.1186/1465-9921-4-7. 本文引用 [1]

[9]	TENHUNEN R, MARVER HS, SCHMID R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase[J]. Proc Natl Acad Sci U S A, 1968, 61(2): 748-755. DOI: 10.1073/pnas.61.2.748. 本文引用 [1]

[10]	MAINES MD. The heme oxygenase system: A regulator of second messenger gases[J]. Annu Rev Pharmacol Toxicol, 1997, 37: 517-554. DOI: 10.1146/annurev.pharmtox.37.1.517. 本文引用 [2]

[11]	RYTER SW, ALAM J, CHOI AMK. Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications[J]. Physiol Rev, 2006, 86(2): 583-650. DOI: 10.1152/physrev.00011.2005. 本文引用 [5]

[12]	BAUER M, BAUER I. Heme oxygenase-1: Redox regulation and role in the hepatic response to oxidative stress[J]. Antioxid Redox Signal, 2002, 4(5): 749-758. DOI: 10.1089/152308602760598891. 本文引用 [1]

[13]	STOCKER R, YAMAMOTO Y, MCDONAGH AF, et al. Bilirubin is an antioxidant of possible physiological importance[J]. Science, 1987, 235(4792): 1043-1046. DOI: 10.1126/science.3029864. 本文引用 [3]

[14]	BALLA G, JACOB HS, BALLA J, et al. Ferritin: A cytoprotective antioxidant strategem of endothelium[J]. J Biol Chem, 1992, 267(25): 18148-18153. 本文引用 [2]

[15]	OTTERBEIN LE, BACH FH, ALAM J, et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway[J]. Nat Med, 2000, 6(4): 422-428. DOI: 10.1038/74680. 本文引用 [3]

[16]	IMMENSCHUH S, RAMADORI G. Gene regulation of heme oxygenase-1 as a therapeutic target[J]. Biochem Pharmacol, 2000, 60(8): 1121-1128. DOI: 10.1016/s0006-2952(00)00443-3. 本文引用 [1]

[17]	RAJU VS, McCOUBREY WK Jr, MAINES MD. Regulation of heme oxygenase-2 by glucocorticoids in neonatal rat brain: Characterization of a functional glucocorticoid response element[J]. Biochim Biophys Acta, 1997, 1351(1-2): 89-104. DOI: 10.1016/s0167-4781(96)00183-2. 本文引用 [1]

[18]	ABRAHAM NG, KAPPAS A. Pharmacological and clinical aspects of heme oxygenase[J]. Pharmacol Rev, 2008, 60(1): 79-127. DOI: 10.1124/pr.107.07104. 本文引用 [3]

[19]	LYU YL, ZHENG W, WANG QH, et al. Research progress of natural active substances against metabolic associated fatty liver disease[J]. Acta Vet Zootechnica Sin, 2025, 56(1): 45-62. 吕永乐, 郑雯, 王签慧, 等. 抗代谢相关脂肪性肝病的天然活性物质研究进展[J]. 畜牧兽医学报, 2025, 56(1): 45-62. 本文引用 [1]

[20]	LOBODA A, DAMULEWICZ M, PYZA E, et al. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: An evolutionarily conserved mechanism[J]. Cell Mol Life Sci, 2016, 73(17): 3221-3247. DOI: 10.1007/s00018-016-2223-0. 本文引用 [1]

[21]

YI Z, BEN DY, XU Y, et al. Herbal cake-separated moxibustion relieves aspirin induced gastric mucosal injury by activating Nrf2/ARE/HO-1 signaling in rats[J]. Acupunct Res, 2023, 48(8): 773-781. DOI: 10.13702/j.1000-0607.20220501. 易展, 贲定严, 徐寅, 等. 隔药饼灸激活Nrf2/ARE/HO-1信号通路修复阿司匹林诱导的胃黏膜损伤的机制研究[J]. 针刺研究, 2023, 48(8): 773-781. DOI: 10.13702/j.1000-0607.20220501. 本文引用 [1]

[22]

WANG XX, FAN GW, PU X, et al. To explore the mechanism of purslane on allergic contact dermatitis in mice based on NrF2/HO-1/NF-κB signaling pathway[J]. Chin J Exp Med Formul, 2025, 31(3): 115-123. DOI: 10.13422/j.cnki.syfjx.20241141. 王小雪, 樊官伟, 蒲翔, 等. 基于Nrf2/HO-1/NF-κB信号通路探讨马齿苋外用对变应性接触性皮炎小鼠的作用机制[J]. 中国实验方剂学杂志, 2025, 31(3): 115-123. DOI: 10.13422/j.cnki.syfjx.20241141. 本文引用 [1]

[23]	CHIEN MH, SHIH PC, DING YF, et al. Curcumin analog, GO-Y078, induces HO-1 transactivation-mediated apoptotic cell death of oral cancer cells by triggering MAPK pathways and AP-1 DNA-binding activity[J]. Expert Opin Ther Targets, 2022, 26(4): 375-388. DOI: 10.1080/14728222.2022.2061349. 本文引用 [1]

[24]

GUO JT, ZHAO TT, YESIMU TLFBK, et al. Mechanistic studies on the anti-DOX cardiotoxicity of polysaccharides of Brassica rapa L. based on the regulation of Nrf2/HO-1 signaling pathway[J]. Acta Pharm Sin, 2024, 59(4): 930-938. DOI: 10.16438/j.0513-4870.2023-1065. 郭君婷, 赵婷婷, 叶斯木·塔拉甫别克, 等. 基于Nrf2/HO-1信号通路调控的恰玛古多糖抗多柔比星心肌毒性的机制研究[J]. 药学学报, 2024, 59(4): 930-938. DOI: 10.16438/j.0513-4870.2023-1065. 本文引用 [1]

[25]

FANG M, HUANG DR, ZHANG JW, et al. Tanshinone IIA exerts anti-hepatocellular carcinoma effects by inhibiting oxidative stress via PI3K/Akt and Nrf2/HO-1 signaling pathway[J]. China J Chin Mater Med, 2024, 49(24): 6724-6734. DOI: 10.19540/j.cnki.cjcmm.20240711.401. 方萌, 黄冬蕊, 张晋玮, 等. 丹参酮ⅡA调控PI3K/Akt与Nrf2/HO-1信号通路抑制氧化应激发挥抗肝细胞癌作用[J]. 中国中药杂志, 2024, 49(24): 6724-6734. DOI: 10.19540/j.cnki.cjcmm.20240711.401. 本文引用 [1]

[26]	GROSSER N, ABATE A, OBERLE S, et al. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin[J]. Biochem Biophys Res Commun, 2003, 308(4): 956-960. DOI: 10.1016/s0006-291x(03)01504-3. 本文引用 [1]

[27]	LIEBER CS. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role[J]. Drug Metab Rev, 2004, 36(3-4): 511-529. DOI: 10.1081/dmr-200033441. 本文引用 [1]

[28]	VALKO M, RHODES CJ, MONCOL J, et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer[J]. Chem Biol Interact, 2006, 160(1): 1-40. DOI: 10.1016/j.cbi.2005.12.009. 本文引用 [1]

[29]	LI M, KIM DH, TSENOVOY PL, et al. Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance[J]. Diabetes, 2008, 57(6): 1526-1535. DOI: 10.2337/db07-1764. 本文引用 [1]

[30]	ALQAHTANI MJ, NEGM WA, SAAD HM, et al. Fenofibrate and Diosmetin in a rat model of testicular toxicity: New insight on their protective mechanism through PPAR-α/NRF-2/HO-1 signaling pathway[J]. Biomed Pharmacother, 2023, 165: 115095. DOI: 10.1016/j.biopha.2023.115095. 本文引用 [1]

[31]	LI DD, YUAN XW, DONG SM, et al. Heme oxygenase-1 prevents non-alcoholic steatohepatitis through modulating mitochondrial quality control[J]. Acta Physiol (Oxf), 2023, 237(3): e13918. DOI: 10.1111/apha.13918. 本文引用 [1]

[32]

BAI WY, YANG Y, HUO SY, et al. Advances in research progress on the therapeutic function of biliverdin[J]. J Kunming Med Univ, 2022, 43(6): 147-153. DOI: 10.12259/j.issn.2095-610X.S20220601. 白文娅, 杨渊, 霍思颖, 等. 胆绿素治疗作用的研究进展[J]. 昆明医科大学学报, 2022, 43(6): 147-153. DOI: 10.12259/j.issn.2095-610X.S20220601. 本文引用 [1]

[33]	JIN XH, XU ZW, CAO J, et al. HO-1/EBP interaction alleviates cholesterol-induced hypoxia through the activation of the AKT and Nrf2/mTOR pathways and inhibition of carbohydrate metabolism in cardiomyocytes[J]. Int J Mol Med, 2017, 39(6): 1409-1420. DOI: 10.3892/ijmm.2017.2979. 本文引用 [1]

[34]	VIJAYAN V, WAGENER FADTG, IMMENSCHUH S. The macrophage heme-heme oxygenase-1 system and its role in inflammation[J]. Biochem Pharmacol, 2018, 153: 159-167. DOI: 10.1016/j.bcp.2018.02.010. 本文引用 [1]

[35]	LEE TS, CHAU LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice[J]. Nat Med, 2002, 8(3): 240-246. DOI: 10.1038/nm0302-240. 本文引用 [1]

[36]

WU LL, ZHENG ZQ, ZHAO M, et al. Based on Nrf2/HO-1/HIF-1α pathway, the regulatory effect of Shengjiang Powder on macrophages in EAE mice was discussed[J]. Lishizhen Med Mater Med Res, 2024, 35(5): 1118-1122. DOI: 10.3969/j.issn.1008-0805.2024.05.21. 吴璐璐, 郑泽泉, 赵敏, 等. 基于Nrf2/HO-1/HIF-1α通路探讨升降散对EAE鼠巨噬细胞的调控作用[J]. 时珍国医国药, 2024, 35(5): 1118-1122. DOI: 10.3969/j.issn.1008-0805.2024.05.21. 本文引用 [1]

[37]	NAITO Y, TAKAGI T, UCHIYAMA K, et al. Heme oxygenase-1: A novel therapeutic target for gastrointestinal diseases[J]. J Clin Biochem Nutr, 2011, 48(2): 126-133. DOI: 10.3164/jcbn.10-61. 本文引用 [1]

[38]	KIM YM, PAE HO, PARK JE, et al. Heme oxygenase in the regulation of vascular biology: From molecular mechanisms to therapeutic opportunities[J]. Antioxid Redox Signal, 2011, 14(1): 137-167. DOI: 10.1089/ars.2010.3153. 本文引用 [1]

[39]	KENSLER TW, WAKABAYASHI N, BISWAL S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway[J]. Annu Rev Pharmacol Toxicol, 2007, 47: 89-116. DOI: 10.1146/annurev.pharmtox.46.120604.141046. 本文引用 [1]

[40]	ZHANG MJ, AN CR, GAO YQ, et al. Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection[J]. Prog Neurobiol, 2013, 100: 30-47. DOI: 10.1016/j.pneurobio.2012.09.003. 本文引用 [1]

[41]

MA C, YANG H. Role of the nuclear factor erythroid 2-related factor 2/heme oxygenase-1 signaling pathway in alcoholic liver disease[J]. J Clin Hepatol, 2023, 39(7): 1708-1713. DOI: 10.3969/j.issn.1001-5256.2023.07.028. 马成, 杨慧. 核因子E2相关因子2/血红素加氧酶-1(Nrf2/HO-1)信号通路在酒精性肝病中的作用[J]. 临床肝胆病杂志, 2023, 39(7): 1708-1713. DOI: 10.3969/j.issn.1001-5256.2023.07.028. 本文引用 [1]

[42]	RUSHWORTH SA, MACEWAN DJ. HO-1 underlies resistance of AML cells to TNF-induced apoptosis[J]. Blood, 2008, 111(7): 3793-3801. DOI: 10.1182/blood-2007-07-104042. 本文引用 [1]

[43]	OLIVEIRA CP, STEFANO JT, CAVALEIRO AM, et al. Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease[J]. J Gastroenterol Hepatol, 2010, 25(2): 357-361. DOI: 10.1111/j.1440-1746.2009.06001.x. 本文引用 [1]

[44]	VOLTI GL, SACERDOTI D, SANGRAS B, et al. Carbon monoxide signaling in promoting angiogenesis in human microvessel endothelial cells[J]. Antioxid Redox Signal, 2005, 7(5-6): 704-710. DOI: 10.1089/ars.2005.7.704. 本文引用 [1]

[45]	KIM HP, RYTER SW, CHOI AMK. CO as a cellular signaling molecule[J]. Annu Rev Pharmacol Toxicol, 2006, 46: 411-449. DOI: 10.1146/annurev.pharmtox.46.120604.141053. 本文引用 [1]

[46]

HUANG HF, PANG XY, DAI WB, et al. Chaihu Shugan Granules improve tetrachloromethane-induced acute liver injury in mice through regulating the Keap1-Nrf2/HO-1 signal pathway[J]. Chin Pharm J, 2024, 59(8): 703-712. DOI: 10.11669/cpj.2024.08.006. 黄海锋, 庞晓妍, 戴卫波, 等. 柴胡疏肝颗粒调控Keap1-Nrf2/HO-1信号通路改善四氯化碳诱导的小鼠急性肝损伤[J]. 中国药学杂志, 2024, 59(8): 703-712. DOI: 10.11669/cpj.2024.08.006. 本文引用 [1]

[47]	WAYAL V, HSIEH CC. Bioactive dipeptides mitigate high-fat and high-fructose corn syrup diet-induced metabolic-associated fatty liver disease via upregulation of Nrf2/HO-1 expressions in C57BL/6J mice[J]. Biomed Pharmacother, 2023, 168: 115724. DOI: 10.1016/j.biopha.2023.115724. 本文引用 [1]

[48]

WAYAL V, WANG SD, HSIEH CC. Novel bioactive peptides alleviate Western diet-induced MAFLD in C57BL/6J mice by inhibiting NLRP3 inflammasome activation and pyroptosis via TLR4/NF-κB and Keap1/Nrf2/HO-1 signaling pathways[J]. Int Immunopharmacol, 2025, 148: 114177. DOI: 10.1016/j.intimp.2025.114177. 本文引用 [1]

[49]	WAYAL V, HSIEH CC. Bioactive dipeptides mitigate high-fat and high-fructose corn syrup diet-induced metabolic-associated fatty liver disease via upregulation of Nrf2/HO-1 expressions in C57BL/6J mice[J]. Biomed Pharmacother, 2023, 168: 115724. DOI: 10.1016/j.biopha.2023.115724. 本文引用 [1]

[50]

MÓZES FE, LEE JA, VALI Y, et al. Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: An individual participant data meta-analysis[J]. Lancet Gastroenterol Hepatol, 2023, 8(8): 704-713. DOI: 10.1016/S2468-1253(23)00141-3. 本文引用 [1]

[51]

LI GY, CHEN WJ, JIA BY, et al. Di’ao Xinxuekang alleviates non-alcoholic steatohepatitis in mice by up-regulating Nrf2/HO-1 signaling pathway[J]. China J Chin Mater Med, 2022, 47(9): 2491-2499. DOI: 10.19540/j.cnki.cjcmm.20211115.401. 李国莺, 陈文静, 贾步云, 等. 地奥心血康上调Nrf2/HO-1信号通路改善小鼠非酒精性脂肪性肝炎的实验研究[J]. 中国中药杂志, 2022, 47(9): 2491-2499. DOI: 10.19540/j.cnki.cjcmm.20211115.401. 本文引用 [1]